Job Search

Latest News

Perosphere and Daiichi Sankyo Enter into a Clinical Trial Agreement.
04/25/13
First Hepatocellular Carcinoma Patient Ph3 Tivantinib.
01/31/13
Top-Line Results in Phase 2 Trial in Tivantinib with Colorectal Cancer.
01/11/13

Stay Connected!

Sign up for free email updates with the latest news about Daiichi Sankyo Careers.

select

Job Details

Newest Jobs in
your area